Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Yan-fang Gong

Matched on OpenAlex author ID A5103409371. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2011: 4 papers · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer. Co-author DOI 10.1080/15384047.2025.2457761↗
  2. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Co-author DOI 10.1080/15384101.2015.1127471↗
  3. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activ… Co-author DOI 10.1016/j.canlet.2013.06.010↗
  4. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Co-author DOI 10.1097/mpa.0b013e3182962acb↗
  5. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Co-author DOI 10.1002/ijc.26422↗
  6. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Co-author DOI 10.1007/s10620-010-1285-3↗
  7. The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro. Last author DOI 10.1007/s11033-010-0632-y↗
  8. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis. Last author DOI 10.1038/ajg.2011.281↗
  9. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. Co-author DOI 10.1186/1756-9966-30-35↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Gao · 9 shared papers, 2011–2025 · strength 0.51
  2. Hongyu Wu · 2 shared papers, 2013–2025 · strength 0.28
  3. Bing Qi · 1 shared paper, 2025 · strength 0.25
  4. Yuqiong Wang · 1 shared paper, 2025 · strength 0.25
  5. Yiqi Du · 6 shared papers, 2011–2016 · strength 0.20
  6. Hongyu Wu · 3 shared papers, 2011–2016 · strength 0.12
  7. Xiangyu Kong · 3 shared papers, 2011–2013 · strength 0.09
  8. Zhaoshen Li · 3 shared papers, 2011–2013 · strength 0.09
  9. Jianqiang Liu · 2 shared papers, 2012–2013 · strength 0.07
  10. Xiaowei Wang · 2 shared papers, 2011–2012 · strength 0.05
  11. Xiaoyan Ning · 1 shared paper, 2016 · strength 0.05
  12. Qiwen Ben · 1 shared paper, 2016 · strength 0.05
  13. Zhao‐Shen Li · 1 shared paper, 2016 · strength 0.05
  14. Zhaoshen Li · 2 shared papers, 2011 · strength 0.05
  15. Jiefang Guo · 1 shared paper, 2013 · strength 0.04
  16. Zhaoshen Li · 1 shared paper, 2013 · strength 0.04
  17. Hui Chen · 1 shared paper, 2013 · strength 0.04
  18. Minghao Liu · 1 shared paper, 2013 · strength 0.04
  19. Ling Zhang · 1 shared paper, 2011 · strength 0.03
  20. Zhaoshen Li · 1 shared paper, 2011 · strength 0.03
  21. Zheng Lu · 1 shared paper, 2011 · strength 0.02
  22. Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
  23. Jianxia Ma · 1 shared paper, 2011 · strength 0.02
  24. Yan Liu · 1 shared paper, 2011 · strength 0.02
  25. Zhendong Jin · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.